Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)
Location: Winston-Salem NC, Chapel Hill NC, Durham NC, Atlanta GA,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 50+
Code: NCT06455085
Recruiting
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
for
Chest Pain
Location: Winston-Salem NC, Charlotte NC, Detroit MI
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 21+
Code: NCT05897632
Recruiting
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
for
Autoimmune Encephalitis, Encephalitis
Location: Winston-Salem NC, Charlottesville VA, Atlanta GA,
Sponsor: University of Utah
Sex: All
Age: 12+
Code: NCT04372615
Phase2, Recruiting
NextGen - Clinical Implication of Next Generation Sequencing
for
Urinary Tract Infections
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: Female
Age: 18 - 70+
Code: NCT05206500
Recruiting
Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy
for
Myotonic Dystrophy
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18 - 65
Code: NCT07362875
Recruiting
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Winston-Salem NC, Chapel Hill NC, Charlotte NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase1, Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Location: Winston-Salem NC, Chapel Hill NC, Charlottesville VA,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase2, Recruiting
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Winston-Salem NC, Charlottesville VA, Richmond VA,